Winning Strategies for Complex Molecules and Drug Products
World Class CMC Expertise
Simplifing
Development.
Big Pharma Background, Biotech Mindset
Accelerating Complex Drug Development
Independent pharmaceutical consulting delivering the scientific depth, executional rigor, and credibility needed to move complex drugs forward—fast.
Speeding molecules to market
Depth & Breadth of Drug Development Expertise
Too often, promising molecules stall or fail not because of biology, but because of poorly integrated or underdeveloped CMC strategy.
PharmaLibre provides pharmaceutical consulting with deep scientific leadership across drug substance development, formulation and manufacturing, analytical development and material characterization, as well biopharmaceutical performance bringing clarity, rigor, and practical execution to de-risk development and efficiently advance complex programs from early discovery through clinical and commercial readiness.
Drug Substance Development and Management
Providing preformulation and candidate selection support, strategic oversight of route selection and process development, impurity and solid-state control, scale-up and tech transfer, and regulatory readiness to advance programs from early development through clinical and commercial stages.
Formulations Development and Manufacturing
Services spanning preclinical through early- and late-stage clinical development, offering fast-to-clinic solutions or fully developed drug products using conventional dosage forms or advanced bioavailability-enhancement approaches, with expert oversight of process development, QbD strategy, scale-up, tech transfer, and GMP manufacturing readiness..
Analytical Methods and Testing
Chemical and solid-state characterization of drug substances and drug products, including method development and validation, impurity profiling, stability assessment, polymorphism and amorphous content evaluation, and data interpretation to support development, manufacturing, and regulatory submissions.
Biopharmaceutical Analysis
Services focused on in-vitro and in-vivo performance assessment, including biorelevant solubility and dissolution strategies, speciation evaluating, intrinsic dissolution, transmembrane flux studies, IVIVC/IVIVR considerations, PK study design and modeling, data interpretation to guide formulation optimization, support regulatory strategy, and inform preclinical and clinical decisions.
Need pharmaLibre's support today?
Common questions answered
PharmaLibre provides independent pharmaceutical consulting and litigation support for complex drug product programs. We work with both large and small biopharma companies, CDMOs, and legal teams to deliver rigorous, practical guidance across formulation development, analytical strategy, manufacturing oversight, and regulatory matters.
How do I get started with PharmaLibre?
Engagements typically begin with an introductory virtual meeting to understand your technical needs, timelines, and objectives. From there, a clearly scoped statement of work is developed outlining deliverables, responsibilities, and next steps. Email info@pharmalibre.com to schedule a meeting today.
Who typically engages PharmaLibre?
Clients include emerging biotech companies, established pharmaceutical manufacturers, CDMOs, and law firms seeking independent scientific expertise to support development decisions or high-stakes litigation matters.
What types of programs does PharmaLibre support?
PharmaLibre supports small-molecule drug products across early development through late-stage and post-approval, including complex oral dosage forms, bioavailability enhancement strategies, analytical and CMC risk assessments, and technology transfer activities. We also support strategy and development of nutraceutical, cosmetic, and consumer products.
Do you provide litigation and expert witness support?
Yes. PharmaLibre provides expert witness and fact witness support in pharmaceutical litigation, including technical analysis of patents and references, evaluation of formulation and manufacturing practices, analytical testing strategy, report review, and rebuttal support.